CompletedPHASE1, PHASE2NCT03745586

Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Insel Gruppe AG, University Hospital Bern
Principal Investigator
Peter Villiger, Prof
University of Bern
Intervention
Tocilizumab(drug)
Enrollment
18 enrolled
Eligibility
50 years · All sexes
Timeline
20182021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03745586 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials